← Back to Clinical Trials
Recruiting NCT04945174

NCT04945174 Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04945174
Status Recruiting
Phase
Sponsor Herlev Hospital
Condition Minor Stroke
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2022-06-01
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Cardiorespiratory exercise combined with patient education and individual follow-up sessions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2022-06-01 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In a randomized controlled trial the effect of 12 weeks of cross-sectorial physical exercise combined with patient education and individual follow-up session is investigated in patients with minor stroke or non-disabling stroke.

Eligibility Criteria

Inclusion Criteria: * Patients with a minor stroke or TIA without the need of rehabilitation after hospital discharge, but need physical activity in order to prevent cardiovascular diseases * Patients spending ≤ 5 hour of leisure time on high-intensity physical activity on weekly basis within the last 3 months * Able to speak and read Danish and to provide informed consent * Individuals ≥ 18 years of age Exclusion Criteria: * Previous large-artery stroke or hemorrhagic stroke * Unstable cardiac condition, e.g. pacemaker * Uncontrolled hypertension (patients not responding adequately to antihypertensive medication when applying treatment according to guidelines) * Symptoms or comorbidities not allowing exercise on a stationary bicycle (e.g. claudication) * Dyspnoea caused by heart or pulmonary disease (e.g. COPD) * Aphasia, or dementia that interferer with understanding the protocol and/or physical examinations. * Patients diagnosed with dementia at hospital admission (a score ≤23/30 on the Mini-Mental State Examination are not invited into the study)

Contact & Investigator

Central Contact

Christina Kruuse, Professor

✉ christina.kruuse@regionh.dk

📞 +45 3868 1233

Principal Investigator

Christina Kruuse, Professor

PRINCIPAL INVESTIGATOR

Herlev Gentofte Hospital, Department of Neurology

Frequently Asked Questions

Who can join the NCT04945174 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Minor Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04945174 currently recruiting?

Yes, NCT04945174 is actively recruiting participants. Contact the research team at christina.kruuse@regionh.dk for enrollment information.

Where is the NCT04945174 trial being conducted?

This trial is being conducted at Copenhagen, Denmark, Herlev, Denmark.

Who is sponsoring the NCT04945174 clinical trial?

NCT04945174 is sponsored by Herlev Hospital. The principal investigator is Christina Kruuse, Professor at Herlev Gentofte Hospital, Department of Neurology. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology